Loading clinical trials...
Loading clinical trials...
Open Label Study of Autologous Bone Marrow Mononuclear Cells in Cerebral Palsy
the purpose of this study was to study the effect of stem cell therapy on common symptoms of cerebral palsy patients.
Age
1 - 22 years
Sex
ALL
Healthy Volunteers
No
Neurogen brain and spine institute
Mumbai, Maharashtra, India
Start Date
August 1, 2010
Primary Completion Date
August 1, 2013
Completion Date
August 1, 2013
Last Updated
October 25, 2018
Autologous bone marrow mononuclear cell transplantation
PROCEDURE
Lead Sponsor
Neurogen Brain and Spine Institute
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07168577